Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 4/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4476002 | 0.98 | MAPT (0.47) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL4487922 | 0.82 | EPHX1 (0.44) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL3400048 | 0.82 | MAPT (0.61) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL78145 | 0.82 | MAPT (0.61) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL4492651 | 0.82 | HRH4 (0.38) | LMNAKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL11526941 | 0.82 | MAPT (0.61) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL4485714 | 0.80 | KCNA3 (0.42) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL9877160 | 0.80 | MAPT (0.45) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL11526739 | 0.79 | MAPT (0.63) | MAPTGAAPOLBLMNAKDM4E | |
| SCHEMBL11476717 | 0.79 | JAK3 (0.38) | MAPTLMNAMEN1KMT2AEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612121-A1 | PROCESS FOR THE PREPARATION OF N,N'-DIALKYL-P-PHENYLENEDIAMINE | LANXESS Deutschland GmbH (DE) | 2025-09-10 | — | — | EP | claimed |
| WO-2024094570-A1 | PROCESS FOR THE PREPARATION OF N,N'-DIALKYL-P-PHENYLENEDIAMINE | LANXESS DEUTSCHLAND GMBH (DE) | 2024-05-10 | — | — | WO | claimed |
| EP-4365163-A1 | METHOD FOR PRODUCING N,N`-DIALKYL-P-PHENYLENEDIAMINE | LANXESS Deutschland GmbH (DE) | 2024-05-08 | — | — | EP | claimed |
| US-20090156441-A1 | Cycloalkyl phenylenediamines as deposit control agents for lubricants | GREAT LAKES CHEMICAL GLOBAL, INC. | 2009-06-18 | — | — | US | claimed |
| EP-4612121-A1 | PROCESS FOR THE PREPARATION OF N,N'-DIALKYL-P-PHENYLENEDIAMINE | LANXESS Deutschland GmbH (DE) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024094570-A1 | PROCESS FOR THE PREPARATION OF N,N'-DIALKYL-P-PHENYLENEDIAMINE | LANXESS DEUTSCHLAND GMBH (DE) | 2024-05-10 | — | — | WO | disclosed |
| EP-4365163-A1 | METHOD FOR PRODUCING N,N`-DIALKYL-P-PHENYLENEDIAMINE | LANXESS Deutschland GmbH (DE) | 2024-05-08 | — | — | EP | disclosed |
| US-8530397-B2 | Additive compositions | INFINEUM INTERNATIONAL LIMITED (GB) | 2013-09-10 | — | — | US | disclosed |
| US-20090156441-A1 | Cycloalkyl phenylenediamines as deposit control agents for lubricants | GREAT LAKES CHEMICAL GLOBAL, INC. | 2009-06-18 | — | — | US | disclosed |
| US-20090156448-A1 | Additive Compositions | LANXESS SOLUTIONS US INC. | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156441-A1 | Cycloalkyl phenylenediamines as deposit control agents for lubricants | C5, C9, C1S | MAPT 2214/4885GAA 3581/4885POLB 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.